Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Patient recruitment ongoing in phase I/II study of imaging agent 89Zr-DFO-daratumumab

Oct. 8, 2018

Fluorescent virus-guided cytology detects active cancer cells in peritoneally disseminated GC

Oct. 5, 2018

Quinoline-based tracers targeting FAP show theranostic potential

Oct. 3, 2018

Optimized neuroimaging with fluorine-18-labeled SV2A PET tracers

Sep. 28, 2018

SGM-101 is safe and effective for intraoperative imaging of pancreatic ductal adenocarcinoma

Sep. 28, 2018

PET tracer for renal imaging tested in vivo

Sep. 21, 2018

First-in-human data for CCR2-targeted PET tracer [64Cu]DOTA-ECL-1i

Sep. 18, 2018

Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease

Sep. 17, 2018

Progenics reports topline phase III data on 1404 in low-grade prostate cancer

Sep. 13, 2018

Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints

Sep. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...